Profilo
Bart Welten served as Chief Financial Officer at Avantium NV from 2020 to 2023, at DSM Resins BV from 2006 to 2012, and at Centrient Pharmaceuticals Netherlands BV in 2018-2019.
He also held the position of Chief Financial Officer at DSM Anti Infectives BV.
Mr. Welten holds an MBA from Boston College and an undergraduate degree from the University of Leiden.
Precedenti posizioni note di Bart Welten
| Società | Posizione | Fine |
|---|---|---|
| AVANTIUM N.V. | Direttore Finanziario/CFO | 01/01/2023 |
Centrient Pharmaceuticals Netherlands BV
Centrient Pharmaceuticals Netherlands BV BiotechnologyHealth Technology Produces green beta-lactams antibiotics | Direttore Finanziario/CFO | 01/02/2019 |
DSM Resins BV | Direttore Finanziario/CFO | 01/07/2012 |
DSM Anti Infectives BV
DSM Anti Infectives BV Pharmaceuticals: MajorHealth Technology Manufactures ingredients for antibiotics | Direttore Finanziario/CFO | - |
Formazione di Bart Welten
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
Boston College
Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Leiden
University of Leiden Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Avantium NV
Avantium NV Industrial MachineryProducer Manufacturing Engages in the development and commercialization of bio-based plastics and chemicals using advanced catalysis research and development | Producer Manufacturing |
DSM Resins BV | |
DSM Anti Infectives BV
DSM Anti Infectives BV Pharmaceuticals: MajorHealth Technology Manufactures ingredients for antibiotics | Health Technology |
Centrient Pharmaceuticals Netherlands BV
Centrient Pharmaceuticals Netherlands BV BiotechnologyHealth Technology Produces green beta-lactams antibiotics | Health Technology |
















